The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory ...

Eligible people in the Black Country are being reminded to come forward for the respiratory syncytial virus (RSV) vaccine.

According to one CDC metric, this flu season is the worst it’s been in 15 years. AHN says its confirmed nearly 3,000 local ...

Research by Public Health Scotland (PHS), published in The Lancet Infectious Diseases Journal, shows uptake of the RSV ...

An RSV vaccine is recommended for all adults age 75 and up, and those ages 60 to 74 who are at increased risk. To prevent severe RSV in infants, officials recommend either maternal vaccination or ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...